The LBR Gene Greenberg Skeletal Dysplasia Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the LBR (Lamin B Receptor) gene, which are associated with Greenberg Skeletal Dysplasia. This rare and severe genetic disorder is characterized by abnormalities in skeletal development, among other symptoms. The test is crucial for early detection, allowing for appropriate medical management and genetic counseling for affected families. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately diagnose this condition. By opting for this test at DNA Labs UAE, individuals can gain valuable insights into their genetic makeup, empowering them with information crucial for making informed health decisions.
The MYO5A gene plays a crucial role in the development and function of various cells within the body, including those involved with pigmentation and immune response. Mutations in the MYO5A gene are responsible for Griscelli syndrome type 1, a rare genetic disorder characterized by pigmentary dilution of the skin and hair, leading to a silvery-gray sheen, and neurological problems without immunodeficiency. This condition is inherited in an autosomal recessive pattern.
To diagnose this specific type of Griscelli syndrome, a genetic test targeting the MYO5A gene can be conducted. DNA Labs UAE offers this specialized genetic testing service. The test is designed to identify mutations in the MYO5A gene that are indicative of Griscelli syndrome type 1. It is a critical tool for accurate diagnosis, allowing for appropriate management and care of affected individuals.
The cost of the MYO5A gene Griscelli syndrome type 1 genetic test at DNA Labs UAE is 4400 AED. This test is an important step for families seeking answers to unexplained symptoms related to pigmentation and neurological issues, providing them with crucial information for genetic counseling and understanding the risk for future offspring.
The MLPH Gene Griscelli syndrome type 3 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the MLPH gene, which are responsible for Griscelli syndrome type 3. This rare genetic disorder is characterized primarily by partial albinism, with patients exhibiting lighter than normal skin and hair coloring, while largely sparing the immune system and neurological function, distinguishing it from other types of Griscelli syndrome.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is crucial for accurate diagnosis and management of the condition. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the MLPH gene.
The cost of the MLPH Gene Griscelli syndrome type 3 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify the genetic alterations associated with the syndrome. Early diagnosis through this test can be essential for managing the condition's symptoms and improving the quality of life for those affected.
The COL9A3 gene plays a crucial role in the development and integrity of the body's connective tissues, including those found in the epiphyses, or the ends of long bones. Mutations in this gene can lead to Epiphyseal Dysplasia, Multiple, Type 3 (EDM3), a genetic disorder characterized by abnormalities in the developing bone and cartilage, which can result in short stature, joint pain, and other skeletal anomalies.
To diagnose this condition accurately, genetic testing for mutations in the COL9A3 gene is essential. DNA Labs UAE offers a specialized genetic test designed to identify mutations in the COL9A3 gene, providing a crucial tool for the diagnosis of Epiphyseal Dysplasia, Multiple, Type 3. This test is particularly important for individuals showing symptoms of the disorder or those with a family history of skeletal abnormalities, as it can confirm the diagnosis and help in managing the condition effectively.
The cost of the COL9A3 gene test at DNA Labs UAE is 4400 AED. This investment includes a comprehensive analysis of the gene to detect any mutations that could lead to EDM3. By choosing DNA Labs UAE for this genetic testing, patients and healthcare providers can expect accurate and reliable results, which are crucial for making informed decisions about treatment and management of the condition.
The MATN3 gene plays a crucial role in the development and maintenance of the skeleton, particularly in the cartilage that forms the growth regions (epiphyses) of bones. Mutations in the MATN3 gene are associated with Epiphyseal Dysplasia, Multiple, Type 5 (EDM5), a rare genetic disorder characterized by abnormalities in the developing bone and cartilage, leading to short stature, joint pain, and early-onset osteoarthritis.
To diagnose this condition, a genetic test focusing on the MATN3 gene can be conducted. This test involves analyzing the DNA to identify mutations in the MATN3 gene that are indicative of EDM5. DNA Labs UAE offers this specific genetic testing service, providing a vital tool for early diagnosis and management of the condition.
The cost of the MATN3 Gene Epiphyseal Dysplasia Multiple Type 5 Genetic Test at DNA Labs UAE is 4400 AED. This test is crucial for families with a history of the disorder, offering them a clear understanding of their genetic status and enabling healthcare providers to tailor management strategies to prevent or mitigate the symptoms associated with this condition.
The DSG1 Gene Erythroderma Congenital with Palmoplantar Keratoderma, Hypotrichosis, and Hyper IgE Genetic Test is a specialized diagnostic examination available at DNA Labs UAE. This test is designed to identify mutations in the DSG1 gene, which are linked to a rare genetic condition characterized by several dermatological and immunological symptoms. Individuals affected by this condition often exhibit erythroderma (redness and scaling of the skin), palmoplantar keratoderma (thickening of the skin on the palms and soles), hypotrichosis (reduced hair growth), and elevated levels of Immunoglobulin E (IgE), a type of antibody that plays a crucial role in the body's immune response.
The test, priced at 4400 AED, involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab, and analyzing it for specific genetic alterations in the DSG1 gene. The results from this test can provide essential information for the diagnosis, management, and potential treatment of this complex condition. It is particularly valuable for affected individuals and their families for understanding the genetic basis of the disorder, informing clinical management, and genetic counseling. DNA Labs UAE is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic testing, ensuring accurate and reliable results.
The GJB3 gene erythrokeratodermia variabilis et progressive genetic test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to identify mutations in the GJB3 gene, which have been associated with the skin conditions erythrokeratodermia variabilis et progressive (EKVP). EKVP is a rare genetic disorder characterized by the development of red, scaly skin patches that can vary in size, shape, and location over time. Additionally, some individuals may experience progressive hearing loss.
DNA Labs UAE employs advanced genetic sequencing technologies to analyze the GJB3 gene, ensuring accurate and reliable results. This test is crucial for individuals with clinical symptoms of EKVP, as it can confirm the diagnosis and aid in the management of the condition. Furthermore, it can provide essential information for families regarding the risk of passing the mutation to future generations.
The cost of the GJB3 gene erythrokeratodermia variabilis et progressive genetic test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and the profound implications of its results for patients and their families, the investment is considered valuable for those seeking clarity on their genetic status concerning EKVP.
The GJB4 gene erythrokeratodermia variabilis et progressive genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the GJB4 gene, which are linked to the development of erythrokeratodermia variabilis et progressive (EKVP). EKVP is a rare genetic skin disorder characterized by transient erythematous patches and persistent keratoderma, impacting the skin's appearance and texture. This condition follows an autosomal dominant inheritance pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
The test is crucial for individuals with a family history of EKVP or those exhibiting symptoms, as it aids in the accurate diagnosis of the condition. By analyzing the DNA for specific genetic alterations in the GJB4 gene, healthcare providers can confirm the presence of EKVP, allowing for personalized management and treatment plans to be developed. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory.
Priced at 4400 AED, the test is a valuable tool in the realm of genetic diagnostics, offering insights into the genetic basis of erythrokeratodermia variabilis et progressive and facilitating informed decisions regarding the care and treatment of affected individuals. DNA Labs UAE, with its commitment to providing accurate and comprehensive genetic testing services, ensures that patients receive reliable results, empowering them with knowledge about their genetic health.
The COX4I2 gene, associated with a unique and rare condition that encompasses exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, plays a critical role in mitochondrial function. This genetic anomaly leads to a spectrum of symptoms, including malabsorption due to the pancreas's inability to produce necessary enzymes, anemia stemming from ineffective erythropoiesis, and abnormal bone growth in the skull. To diagnose this condition accurately, genetic testing is paramount.
DNA Labs UAE offers a specialized genetic test designed to identify mutations in the COX4I2 gene, providing crucial information for diagnosing this complex syndrome. The test is a vital tool for healthcare professionals to establish a definitive diagnosis, enabling them to tailor treatment plans effectively and provide genetic counseling for affected families.
The cost of this comprehensive genetic test is 4400 AED. Conducted in state-of-the-art facilities, the test ensures high accuracy and reliability, with results that can guide clinical decisions and support patient management. For families and individuals facing the possibility of this condition, the test represents a critical step towards understanding and managing the associated health challenges.
The EXT1 Gene Exostoses Multiple Type 1 Genetic Test is a specialized diagnostic tool designed to detect mutations in the EXT1 gene, which are associated with Hereditary Multiple Exostoses (HME) type 1, a genetic disorder characterized by the growth of multiple benign bone tumors. These tumors, known as exostoses or osteochondromas, primarily affect the growth of long bones and can lead to pain, deformity, and potential complications such as nerve compression.
This test is crucial for individuals with a family history of HME or those exhibiting symptoms suggestive of the condition, as early detection can lead to better management and treatment strategies. Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test provides a thorough analysis of the EXT1 gene to identify mutations that cause the disorder.
The cost of the EXT1 Gene Exostoses Multiple Type 1 Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to ascertain the presence of genetic mutations in the EXT1 gene, offering invaluable insights for affected individuals and their families. With the results, healthcare providers can develop a more informed approach to the management and treatment of Hereditary Multiple Exostoses, improving the quality of life for those diagnosed with this condition.
